The role of fish oil in managing bipolar II disorder

Bipolar II Disorder: Modelling, Measuring and Managing, Second Edition

Volumn , Issue , 2012, Pages 133-141

  Rees, Anne Marie ^a   Parker, Gordon ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870866347     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9781139003315.014     Document Type: Chapter

References (24)

1. Amminger, P. G., Schafer, M. R., Konstantinos, P. et al. (2010). Long-chain n − 3 fatty acids for indicated prevention of psychotic disorders. Archives of General Psychiatry, 67, 146–154.
2. Chiu, C. C., Huang, S. Y., Su, K. P. et al. (2003). Polyunsaturated fatty acid dei cit in patients with bipolar mania. European Neuropsychopharmacology, 13, 99–103.
3. Chiu, C. C., Huang, S. Y., Chen, C. C. and Su, K. P. (2005). Omega-3 fatty acids are more benei cial in the depressive phase than in the manic phase in patients with bipolar I disorder. (Letter to the Editor.) Journal of Clinical Psychiatry, 66, 1613–1614.
4. Frangou, S., Lewis, M. and McCrone, P. (2006). Ei cacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised doubleblind placebo-controlled study. British Journal of Psychiatry, 188, 46–50.
5. Gracious, B. L., Chirieac, M. C. and Costescu, M. C. (2010). Randomised placebo-controlled trial of l ax oil in pediatric bipolar disorder. Bipolar Disorders, 12, 142–154.
6. Hamazaki, K., Choi, K. H. and Kim, H.Y. (2010). Phospholipid proi le in the postmortem hippocampus of patients with schizophrenia and bipolar disorder. Journal of Psychiatric Research, 44, 688–693.
7. Hibbeln, J. R. (1998). Fish consumption and major depression. Lancet, 351, 1213.
8. Hibbeln, J. R., Nieminen L. R. G., Blasbaly, T. L. et al. (2006). Healthy intakes of n − 3 and n − 6 fatty acids: estimations considering worldwide diversity. American Journal of Clinical Nutrition, 83(suppl), S1483–S1493.
9. Hirashima, F., Parow, A., Stoll, A. et al. (2004). Omega-3 fatty acid treatment and T2 whole brain relaxation times in bipolar disorder. American Journal of Psychiatry, 161, 1922–1924.
10. Keck, P. E. Jr, McElroy, S. L., Mintz, J. et al. (2006). Double-blind, placebo-controlled trials of ethyl-eicosapentaenoate in the treatment of bipolar depression and rapid-cycling bipolar disorder. Biological Psychiatry, 60, 1020–1022.
11. Kinrys, G. (2000). Are omega-3 fatty acids beneficial in depression but not mania? In reply. Archives of General Psychiatry, 57, 716–717.
12. Marangell, L. B., Suppes, T., Ketter, T. A. et al. (2006). Omega-3 fatty acids in bipolar disorder: clinical and research considerations. Prostaglandins, Leukotrienes and Essential Fatty Acids, 75, 315–321.
13. Martin, J. G. (2009). EPA but not DHA appears to be responsible for the ei cacy of omega-3 long chain polyunsaturated supplementation in depression. Journal of American College of Nutrition, 28, 525–542.
14. McNamara, R. K., Jandacek, R., Rider, T. et al. (2008). Dei ciency in DHA and associated elevations in the metabolism of AA and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder. Psychiatry Research, 160, 285–299.
15. McNamara, R. K., Jandacek, R., Rider, T. et al. (2010). Selective dei cits in erythrocyte DHA composition in adult patients with bipolar disorder and major depressive disorder. Journal of Af ective Disorders, 126, 303–311.
16. Noaghuil, S. and Hibbeln, J. R. (2003). Cross-national comparisons of seafood consumption and rates of bipolar disorders. American Journal of Psychiatry, 160, 2222–2227.
17. Osher, Y., Bersudsky, Y. and Belmaker, R. H. (2005). Omega-3 eicosapentaenoic acid in bipolar depression: report of a small openlabel study. Journal of Clinical Psychiatry, 66, 726–729.
18. Owen, C., Rees, A-M. and Parker, G. (2008). The role of fatty acids in the development and treatment of mood disorders. Current Opinion in Psychiatry, 21, 19–24.
19. Parker, G., Gibson, N., Brotchie, H., Heruc, G., Rees, A-M. and Hadzi-Pavlovic, D. (2006). Omega-3 fatty acids and mood disorders. American Journal of Psychiatry, 163, 969–978.
20. Rao, J. S., Lee, H-J., Rapoport, S. I. and Bazinet, R. P. (2008). Mode of action of mood stabilizers: is the AA cascade a common target. Molecular Psychiatry, 13, 585–596.
21. Sampath, H. and Ntambi, J. M. (2004). Polyunsaturated fatty acid regulation of gene expression. Nutrition Review, 62, 333–339.
22. Stoll, A. L., Locke, L. B., Marangell, L. B. and Severus, W. E. (1999a). Omega-3 fatty acids and bipolar disorder: a review. Prostaglandins, Leukotrienes and Essential Fatty Acids, 60, 329–337.
23. Stoll, A. L., Severus, W. E., Freeman, M. P. et al. (1999b). Omega-3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Archives of General Psychiatry, 56, 407–412.
24. Stoll, A. L., Damico, K. E., Marangell, L. B. and Severus, W. E. (2000). Reply to Su, K-P., Shen W. W., Huang S-Y.: Are omega-3 fatty acids benei cial in depression but not mania? (letter). Archives of General Psychiatry, 57, 716–717.